Back to today’s briefing

Story perspectives

New Compound PSB-172656 Could Revolutionize Allergy Treatments

4/26/2025

35 5

Summary

Story summary

A groundbreaking compound, PSB-172656, developed by researchers at the University of Bonn, holds the potential to block the MRGPRX2 receptor linked to severe allergies such as asthma and irritable bowel syndrome. This innovative treatment could pave the way for life-saving interventions, pending further human trials. The promising findings are detailed in Signal Transduction and Targeted Therapy.

1 of 1

Story summary

A groundbreaking compound, PSB-172656, developed by researchers at the University of Bonn, holds the potential to block the MRGPRX2 receptor linked to severe allergies such as asthma and irritable bowel syndrome. This innovative treatment could pave the way for life-saving interventions, pending further human trials. The promising findings are detailed in Signal Transduction and Targeted Therapy.